✦ LIBER ✦

Antitumor Activity of Gemcitabine and Oxaliplatin Is Augmented by Thymoquinone in Pancreatic Cancer

✍ Scribed by Banerjee, S.; Kaseb, A. O.; Wang, Z.; Kong, D.; Mohammad, M.; Padhye, S.; Sarkar, F. H.; Mohammad, R. M.

Book ID: 121721139
Publisher: American Association for Cancer Research
Year: 2009
Tongue: English
Weight: 773 KB
Volume: 69
Category: Article
ISSN: 0008-5472
DOI: 10.1158/0008-5472.can-08-4235

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of Combination of EMAP II with D

Effects of Combination of EMAP II with Doxorubicin, Docetaxel, Oxaliplatin and Gemcitabine to Enhance Antitumor Activity in Pancreatic Cancer

✍ N. Awasthi; M.A. Schwarz; R.E. Schwarz 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Toxicity study of gemcitabine, oxaliplat

Toxicity study of gemcitabine, oxaliplatin, and bevacizumab, followed by 5-fluorouracil, oxaliplatin, bevacizumab, and radiotherapy, in patients with locally advanced pancreatic cancer

✍ Davendra P. S. Sohal, James M. Metz, Weijing Sun… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 314 KB

Synergistic activity of troxacitabine (T

Synergistic activity of troxacitabine (Troxatyl™) and gemcitabine in pancreatic cancer

✍ Vijaya L Damaraju; David Y Bouffard; Clarence KW Wong; Marilyn L Clarke; John R 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 377 KB

Molecular Evidence for Increased Antitum

Molecular Evidence for Increased Antitumor Activity of Gemcitabine by Genistein In vitro and In vivo Using an Orthotopic Model of Pancreatic Cancer

✍ Banerjee, S. 📂 Article 📅 2005 🏛 American Association for Cancer Research 🌐 English ⚖ 698 KB

Restoring sensitivity to oxaliplatin by

Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivo

✍ Sanjeev Banerjee; Dejuan Kong; Asfar S. Azmi; Zhiwei Wang; Aamir Ahmad; Seema Se 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 723 KB

## Abstract __This article has been retracted at the request of__: Editor‐in‐Chief and Co‐author ‘Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine‐resistant pancreatic cancer cells __in vitro__ and __in vivo__’ by Banerjee, S., Kong, D., Azmi, A. S., Wang, Z., Ahmad, A., Set

Antitumor Activity of Gemcitabine Can Be

Antitumor Activity of Gemcitabine Can Be Potentiated in Pancreatic Cancer through Modulation of TLR4/NF-κB signaling by 6-Shogaol

✍ Zhou, Ling; Qi, Lianwen; Jiang, Lifeng; Zhou, Ping; Ma, Jiang; Xu, Xiaojun; Li, 📂 Article 📅 2014 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 857 KB